Protara Therapeutics (TARA) Total Liabilities (2013 - 2026)

Protara Therapeutics' Total Liabilities history runs 14 years deep, the most recent figure standing at $10.7 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 6.35% year-over-year to $10.7 million; the TTM figure through Mar 2026 stood at $10.7 million (up 6.35% YoY), while the FY2025 annual figure was $13.1 million, down 8.83% from the prior year.
• Total Liabilities was $10.7 million for Q1 2026 at Protara Therapeutics, down from $13.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $14.3 million in Q4 2024 to a low of $9.0 million in Q1 2022.
• Historically, Total Liabilities has averaged $11.0 million across 5 years, with a median of $10.7 million in 2026.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities soared 110.43% in 2022, then dropped 16.4% in 2024.
• A 5-year view of Total Liabilities shows it stood at $11.2 million in 2022, then dropped by 5.12% to $10.6 million in 2023, then surged by 34.68% to $14.3 million in 2024, then declined by 8.83% to $13.1 million in 2025, then slipped by 17.93% to $10.7 million in 2026.
• The last three Total Liabilities figures came in at $10.7 million (Q1 2026), $13.1 million (Q4 2025), and $12.3 million (Q3 2025), per Business Quant data.